RxDoctor Payments Data

Kathleen Shemberger

Nurse Practitioner · Sahuarita, AZNPI 1467047308

Payments from drug & device makers

$1,136in general payments, 2019–2025

Across 18 payments — averaging $63.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$379
  • Alkermes, Inc.$159
  • Merck$138
  • Silk Road Medical, Inc.$124
  • AbbVie$117
  • Gilead$86
  • plus $134 from 4 others

What the payments were for

  • Food & beverage$1,136100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,136 in reported general payments places this provider in the 80th percentile of 1,719 nurse practitioner providers in Arizona.

See all nurse practitioner providers in Arizona

Medicare billing

Part B allowed, 2024
$343
Medicare patients
26
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$51,762
TrulicityDulaglutide31$48,567
EliquisApixaban36$47,800
OzempicSemaglutide14$21,078
JanuviaSitagliptin Phosphate16$19,375
ProliaDenosumab11$18,909
FarxigaDapagliflozin Propanediol15$17,542
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$4,665
LantusInsulin Glargine,hum.Rec.Anlog30$3,904
Atorvastatin Calcium244$2,182
Losartan Potassium197$1,981
Levothyroxine Sodium264$1,978
Albuterol Sulfate HfaAlbuterol Sulfate59$1,482
Omeprazole83$1,424
Metformin Hcl156$1,138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$138$19,37516 claims
AstraZenecaFarxiga$379$17,54215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,719 nurse practitioner providers in Arizona.

Other nurse practitioner in Sahuarita

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →